Regeneron Pharmaceuticals REGN
NASDAQ REGN
$827.72 -15.75 (-1.87%)
As of: Sep 4, 2026 · 3:59 PM EDT

Regeneron Pharmaceuticals (REGN) Preferred Shares (2009)

Regeneron Pharmaceuticals (REGN) posted quarterly Preferred Shares of $2000.0 for Q4 2009.

Analysis

Regeneron Pharmaceuticals (REGN) Preferred Shares (2009) Analysis & Trends

Regeneron Pharmaceuticals' Preferred Shares history runs 1 years deep, the most recent figure standing at $2000.0 for Q4 2009.

  • In Q4 2009, Preferred Shares changed N/A year-over-year to $2000.0; the TTM figure through Dec 2009 stood at $2000.0 (changed N/A YoY), while the FY2009 annual figure was $2000.0, changed N/A from the prior year.
  • Preferred Shares for Q4 2009 stood at $2000.0.
  • The five-year high for Preferred Shares was $2000.0 in Q4 2009, with the low at $2000.0 in Q4 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 2,000.00